FSMEX vs. FPHAX
Compare and contrast key facts about Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX).
FSMEX is managed by Fidelity. It was launched on Apr 28, 1998. FPHAX is managed by Fidelity. It was launched on Jun 17, 2001.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: FSMEX or FPHAX.
Key characteristics
| FSMEX | FPHAX | |
|---|---|---|
| YTD Return | 10.93% | 18.95% |
| 1Y Return | 33.72% | 26.86% |
| 3Y Return (Ann) | -7.46% | 3.59% |
| 5Y Return (Ann) | 4.10% | 5.95% |
| 10Y Return (Ann) | 6.54% | 3.97% |
| Sharpe Ratio | 1.94 | 1.51 |
| Sortino Ratio | 2.70 | 2.17 |
| Omega Ratio | 1.34 | 1.26 |
| Calmar Ratio | 0.72 | 1.64 |
| Martin Ratio | 7.25 | 6.29 |
| Ulcer Index | 4.23% | 3.74% |
| Daily Std Dev | 15.83% | 15.53% |
| Max Drawdown | -43.45% | -37.34% |
| Current Drawdown | -23.07% | -11.24% |
Correlation
The correlation between FSMEX and FPHAX is 0.74, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
FSMEX vs. FPHAX - Performance Comparison
In the year-to-date period, FSMEX achieves a 10.93% return, which is significantly lower than FPHAX's 18.95% return. Over the past 10 years, FSMEX has outperformed FPHAX with an annualized return of 6.54%, while FPHAX has yielded a comparatively lower 3.97% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FSMEX vs. FPHAX - Expense Ratio Comparison
FSMEX has a 0.68% expense ratio, which is lower than FPHAX's 0.75% expense ratio.
Risk-Adjusted Performance
FSMEX vs. FPHAX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
FSMEX vs. FPHAX - Dividend Comparison
FSMEX has not paid dividends to shareholders, while FPHAX's dividend yield for the trailing twelve months is around 0.72%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FSMEX Fidelity Select Medical Technology and Devices Portfolio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 11.71% | 5.17% | 9.84% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 0.72% | 0.63% | 1.33% | 1.17% | 1.31% | 1.31% | 1.44% | 1.33% | 1.07% | 5.59% | 5.81% | 11.12% |
Drawdowns
FSMEX vs. FPHAX - Drawdown Comparison
The maximum FSMEX drawdown since its inception was -43.45%, which is greater than FPHAX's maximum drawdown of -37.34%. Use the drawdown chart below to compare losses from any high point for FSMEX and FPHAX. For additional features, visit the drawdowns tool.
Volatility
FSMEX vs. FPHAX - Volatility Comparison
The current volatility for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) is 4.09%, while Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a volatility of 4.52%. This indicates that FSMEX experiences smaller price fluctuations and is considered to be less risky than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.